A similar range of increased uptake of F3 peptide-(also rhodamine-labeled) targeted liposomes herein used (9.7–17-fold) by nucleolin-overexpressing cell lines had been previously observed, namely in triple-negative breast cancer as the MDA-MB-231 cells [27]. Here, NUCLEOLIN is linked to triple-negative breast carcinoma.